Top Markets
#1 Wiki Cat Wiki Cat +47.71%
#2 Siren Siren +35.56%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.11%
#4 Ribbita by Virtuals Ribbita by Virtuals +20.01%
#5 PulseChain PulseChain +17.72%
#6 Velvet Velvet +17.19%
#7 KUB Coin KUB Coin +17.15%
#8 OpenEden OpenEden +16.37%
#9 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +16.32%
#10 aPriori aPriori +16.24%
Coin of the day
Wiki Cat Wiki Cat
Settings
Language
ENGLISH
Currency
USD
Theme
Skye Bioscience, Inc. Skye Bioscience, Inc.

Skye Bioscience, Inc.

SKYE
Rank in Stocks #31149
Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on... Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. is headquartered in San Diego, California.
Share Price
$0.38
Market Cap
$13.35M
Change (1 day)
-8.46%
Change (1 year)
-88.79%
Country
US
Trade Skye Bioscience, Inc. (SKYE)

Category

Healthcare
Number of shares outstanding for Skye Bioscience, Inc. (SKYE)
Number of shares outstanding as of August 2026: 0
According to Skye Bioscience, Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Skye Bioscience, Inc. (SKYE) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 483.58M -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -
BE